Log in
Enquire now
‌

US Patent 8206934 Methods for diagnosing ovarian cancer

Patent 8206934 was granted and assigned to Vermillion, Inc. on June, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Vermillion, Inc.
Vermillion, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8206934
Patent Inventor Names
Mats Brannstrom0
Karin Sundfeldt0
Vladimir Podust0
Tai-Tung Yip0
Bjorg Kristjansdottir0
Eric Thomas Fung0
Date of Patent
June 26, 2012
Patent Application Number
12584832
Date Filed
September 11, 2009
Patent Primary Examiner
‌
Sean Aeder
Patent abstract

The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry, immunoassay, or other means.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8206934 Methods for diagnosing ovarian cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.